WB
ACAD icon

WesBanco Bank’s Acadia Pharmaceuticals ACAD Stock Holding History

WesBanco Bank’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.74M Hold
78,200
– – 0.05% 262
2025
Q4 		$2.09M Hold
78,200
– – 0.06% 223
2025
Q3 		$1.67M Hold
78,200
– – 0.05% 276
2025
Q2 		$1.69M Buy
78,200
+26,400
+51% +$491K 0.05% 262
2025
Q1 		$860K Hold
51,800
– – 0.03% 338
2024
Q4 		$951K Hold
51,800
– – 0.03% 322
2024
Q3 		$797K Hold
51,800
– – 0.03% 357
2024
Q2 		$842K Buy
51,800
+25,000
+93% +$403K 0.03% 329
2024
Q1 		$496K Buy
+26,800
New +$664K 0.02% 415

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

WesBanco Bank's ACAD Position: Q1 2026 in Review

WesBanco Bank held its Acadia Pharmaceuticals (ACAD) position steady in Q1 2026 at 78,200 shares worth $1.74M. The position accounts for 0.05% of the portfolio, ranked #262.

WesBanco Bank first reported a position in ACAD in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.09M in Q4 2025. 340 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • WesBanco Bank held 78,200 shares of Acadia Pharmaceuticals worth $1.74M as of Q1 2026.
  • WesBanco Bank left its Acadia Pharmaceuticals share count unchanged in Q1 2026.
  • Acadia Pharmaceuticals made up 0.05% of WesBanco Bank's portfolio in Q1 2026, its #262 holding.
  • WesBanco Bank first reported a position in Acadia Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • WesBanco Bank's Acadia Pharmaceuticals position peaked at $2.09M in Q4 2025.
  • 340 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on WesBanco Bank's 13F filing for Q1 2026, filed 21 Apr 2026.